The efficacy of new bipolar hemostatic forceps for endoscopic resection

The efficacy of new bipolar hemostatic forceps for endoscopic resection - The efficacy of new hemostatic forceps for ER

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024375

Enrollment

Registered

2016-10-13

Start date

2016-10-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the gastrointestinal tumor

Interventions

new bipolar hamostatic forceps

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient for gastrointestinal tumor and subjected to endoscopic resection.

Exclusion criteria

Exclusion criteria: Patient who judged that we were inappropriate to perform examination safely.

Design outcomes

Primary

Measure	Time frame
the successful rate of hemostasis	—

Countries

Japan

Contacts

Public ContactYasutoshi Ochiai

Keio University Center for Research and Development of Minimally Invasive Treatment, Cancer Center

yochiai.a7@keio.jp03-5363-3437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026